Latest news
Mediar partners with Ono Pharma on fibro-inflammatory discovery - AllSciAllSci · Thu, 06 Aug 2026 16:25:44 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMTForlong advances IL-15 superagonist into Australian Phase I trial with subcutaneous dosing - AllSciAllSci · Wed, 05 Aug 2026 10:31:21 GMT